Cohort Study of PPP Injections for Athletes With Muscle Injury
NCT: NCT07566039 · NOT_YET_RECRUITING
Brief Summary
The investigators hypothesize that a single injection of platelet-poor plasma (PPP) into an acute muscle injury will significantly improve local muscle regeneration and patient outcomes compared to the standard of care using only ultrasound-guided hematoma aspiration. Muscle regeneration will be assessed through quantitative MRI analysis. The investigators anticipate that PPP injections will lead to a measurable reduction in scar tissue and an increase in regenerated muscle tissue at the injury site over a six-month period.
Frequently Asked Questions
What is Cohort Study of PPP Injections for Athletes With Muscle Injury?
Cohort Study of PPP Injections for Athletes With Muscle Injury is a clinical trial registered under NCT07566039. Current status: NOT_YET_RECRUITING.
What is the status of NCT07566039?
The current status of NCT07566039 (Cohort Study of PPP Injections for Athletes With Muscle Injury) is: NOT_YET_RECRUITING.
When did Cohort Study of PPP Injections for Athletes With Muscle Injury start?
Cohort Study of PPP Injections for Athletes With Muscle Injury started on 2026-05-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.